NHC Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
National Healthcare Corp (NHC) is not a strong buy for a beginner, long-term investor at this time. While the stock has shown bullish technical indicators, the overbought RSI and negative short-term stock trend projections (-3.44% in the next week, -5% in the next month) suggest potential downside risk. Additionally, the company's financial performance in Q3 2025 shows revenue growth but declining net income and EPS, which could indicate challenges in profitability. With no significant trading trends, news catalysts, or strong proprietary trading signals, it is advisable to hold off on buying this stock for now.
The stock shows bullish moving averages (SMA_5 > SMA_20 > SMA_200) and a positive MACD histogram (2.281), indicating an upward trend. However, the RSI is at 91.726, signaling an overbought condition. Key resistance levels are at R1: 168.555 and R2: 176.279, with support at S1: 143.549 and S2: 135.825.
Gross margin improved by 5.86% YoY to 36.15%.
Stock trend analysis predicts a -3.44% decline in the next week and -5% in the next month. RSI indicates overbought conditions.
In Q3 2025, revenue increased to $382.66M (up 12.48% YoY), but net income dropped to $39.24M (down -8.30% YoY), and EPS decreased to 2.5 (down -8.42% YoY). Gross margin improved to 36.15% (up 5.86% YoY).
No recent analyst rating or price target changes available.
